Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) EPS (Basic): 2009-2025

Historic EPS (Basic) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$0.13.

  • Cumberland Pharmaceuticals' EPS (Basic) fell 18.18% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year increase of 68.83%. This contributed to the annual value of -$0.46 for FY2024, which is 4.55% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported EPS (Basic) of -$0.13 as of Q3 2025, which was down 160.00% from -$0.05 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year EPS (Basic) high stood at $0.08 for Q2 2021, and its period low was -$0.44 during Q4 2023.
  • In the last 3 years, Cumberland Pharmaceuticals' EPS (Basic) had a median value of -$0.08 in 2024 and averaged -$0.09.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' EPS (Basic) spiked by 172.73% in 2021, and later plummeted by 1,500.00% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.29 in 2021, then surged by 41.38% to -$0.17 in 2022, then tumbled by 158.82% to -$0.44 in 2023, then skyrocketed by 68.18% to -$0.14 in 2024, then declined by 18.18% to -$0.13 in 2025.
  • Its last three reported values are -$0.13 in Q3 2025, -$0.05 for Q2 2025, and $0.08 during Q1 2025.